Lima, M, Rudd, T and Yates, E (2017) New applications of heparin and other glycosaminoglycans. Molecules, 22 (5). 749 - 749. ISSN 1420-3049

[thumbnail of M Lima - New applications of Heparin and other glycosaminoglycans.pdf]
M Lima - New applications of Heparin and other glycosaminoglycans.pdf - Published Version
Available under License Creative Commons Attribution.

Download (244kB) | Preview


Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a century. Its introduction reduced clotting risks substantially and subsequent developments, including the introduction of low-molecular-weight heparin, made possible many major surgical interventions that today make heparin an indispensable drug. There has been a recent burgeoning of interest in heparin and related glycosaminoglycan (GAG) polysaccharides, such as chondroitin sulfates, heparan sulfate, and hyaluronate, as potential agents in various applications. This ability arises mainly from the ability of GAGs to interact with, and alter the activity of, a wide range of proteins. Here, we review new developments (since 2010) in the application of heparin and related GAGs across diverse fields ranging from thrombosis and neurodegenerative disorders to microbiology and biotechnology.

Item Type: Article
Additional Information: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Uncontrolled Keywords: heparin; glycosaminoglycans; chondroitin sulfate
Subjects: Q Science > QH Natural history
Divisions: Faculty of Natural Sciences > School of Life Sciences
Depositing User: Symplectic
Date Deposited: 22 May 2019 08:14
Last Modified: 24 May 2019 10:09

Actions (login required)

View Item
View Item